Tuesday, 28 September - Friday, 1 October 2021
The EASD Abstract Submission System available via MyEASD will close on the deadline 1 April 2021 at 18:00hrs CEST.
Communications must be delivered in English. There is no simultaneous translation.
It is not permitted to take photographs and/or film during any of the sessions.
Receipt of Abstract
Abstracts can only be submitted online and MUST be submitted BEFORE 1 APRIL 2021 18:00hrs CEST. THIS DEADLINE WILL BE STRICTLY ENFORCED, as will be the regulations given below. The EASD office will notify the presenting (= first named) author when the abstracts with the status "complete" are forwarded for anonymous review.
Submission of Abstracts
The following is a brief overview of the abstract submission process. Please read carefully the DETAILED ABSTRACT SUBMISSION GUIDELINES before you begin the abstract submission process.
It is not permitted to submit work that has been published and/or is likely to be published before the EASD Abstract submission deadline (1 April 2021, 18:00hrs. CEST). The Programme Committee has the right to remove an abstract if this contains data that has already been published. However, EASD accepts the submission of abstracts that have been presented in recent months at local or national diabetes meetings (e.g. ADA, DDG). An author submitting or presenting work that has been published in a journal before the EASD Abstract submission deadline (1 April 2021, 18:00hrs CEST) will be banned from presenting data at the EASD Meetings for three years.
Abstracts submitted on Human Studies:
The box must be marked stating that the study has been reviewed by the Local Ethics Committee and that it has therefore been performed in accordance with the ethical standards laid down in the Helsinki Declaration (see World Medical Association: https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/).
Abstracts submitted on Animal Studies:
The box must be marked stating that the study has been carried out along the “Principles of laboratory animal care” (NIH Publication no. 85-23, revised 1985) and according to the national law, if applicable.
Selection of abstracts for the Scientific Programme is made anonymously. THE ABSTRACT MUST BE SUBMITTED as follows:
Each author can be listed ONLY ONCE as the PRESENTING author (presenting author is always the first named author in the author block) on ONE (1) abstract. Each additional abstract will be removed from the system and will not be forwarded to the Review Committee. Additional abstracts will not be reviewed. Presenting authors may be co-authors of other abstracts. It is mandatory that the presenting author of any abstract accepted for presentation or discussion attends the 57th virtual EASD Annual Meeting 2021 to present and/or discuss his/her paper. Failure to do so, without prior or adequate explanation sent to the EASD Office by e-mail, may result in the author or the institution being banned from presenting abstracts for the next three years.
Abstracts are welcome from non-members of EASD. Please refer to the Registration section of this General Information, regarding the date by which authors must become members of EASD in order to qualify for preferential registration fees. These regulations will be strictly enforced.
The abstract must be submitted in English. New authors should create an account using a login name and a password. With this information they can revise the submission as often as required, make changes, additions, amendments, change/add/delete authors, copy special characters easily into the text, re-write the abstract or copy and paste the text in the corresponding boxes. All this is possible until the Abstract Submission Deadline: 1 April 2021 18:00hrs CEST. After this date the submission site will be closed.
IMPORTANT!: Always double check that the “complete” status of your submitted abstract has NOT been affected after having edited it.
CHANGES TO THE CONTENT AND/OR THE AUTHOR BLOCK OF THE SUBMITTED ABSTRACT WILL NOT BE ACCEPTED after the submission deadline.
Your abstract submission must adhere the following structure:
Once all submission steps have been successfully completed and the abstract deadline has passed, the presenting author will receive a notification confirming the final version of the abstract submission. In case of questions, or if you have not received a notification confirming the final version of the abstract submission by 15 April 2021, please contact the EASD office: firstname.lastname@example.org
One keyword from the list below must be selected for the submission:
GROUP 1: Human Genetics/ Epigenetics/ Epidemiology
02 Genetics of type 1 diabetes
03 Genetics of type 2 diabetes
04 Monogenic forms of diabetes
05 Environmental factors (viruses, nutrients, toxins)
06 Diabetes epigenetics
07 Prediction and prevention of type 1 diabetes
08 Prediction of type 2 diabetes
09 Prevention of type 2 diabetes
10 Risk of diabetes in immigrant populations
GROUP 2: Islets/ Transplantation/ Immunology of type 1 diabetes
11 Stem cells and beta cell generation
12 Transcriptional regulation and protein synthesis in the pancreas
13 Insulin secretion in vitro and exocytosis
14 Beta cell signal transduction
15 Beta cell damage, degeneration and apoptosis
16 Experimental immunology and animal models of type 1 diabetes
17 Clinical immunology
18 Pancreas and islet transplantation
GROUP 3: Pathophysiology/ Metabolism I
19 Insulin action
20 Insulin sensitivity and resistance
21 Insulin secretion in vivo
22 Gastro-entero pancreatic factors
23 Other hormones
24 Glucose transport
25 Carbohydrate metabolism
26 Protein metabolism
27 Exercise physiology
29 Diabetes in childhood
GROUP 4: Pathophysiology/ Metabolism II
30 Inflammation in type 2 diabetes
31 Animal models of type 2 diabetes and complications
32 Lipid metabolism
33 Adipose tissue biology and adipocytokines
34 Inflammation in obesity
35 Animal models of obesity
36 Weight regulation and obesity
37 Brain metabolism
38 Ageing and diabetes
GROUP 5: Clinical Science and Care I
39 Nutrition and diet
40 Oral therapies: metformin, sensitizers and other non-secretagogues
41 SGLT inhibitors
42 Incretin based therapies
43 Novel agents
GROUP 6: Clinical Science and Care II
44 Insulin therapy
47 Health care delivery
49 Psychological aspects
50 Socio-economic aspects
51 Digital diabetes health
GROUP 7: Complications I
52 Neuropathy: somatic
53 Neuropathy: autonomic, incl. erectile dysfunction
54 Diabetic foot and skin disorders
GROUP 8: Complications II/ Comorbidities
58 Cardiac complications
59 Macrovascular disease
60 Pathogenic mechanisms/ complications
61 Dyslipidaemia, lipoproteins
62 Animal models of complications
63 Cancer and other complications
65 Non-alcoholic fatty liver disease (NAFLD)
Preference for oral presentation or short oral discussion is not possible. The Programme Committee allocates the accepted abstracts to either an oral presentation or a short oral discussion session. The Programme Committee Members will meet in May 2021 and have the absolute right to accept or reject abstracts. Their decision is final. Only accepted abstracts will be published in the Abstract Volume. The Programme Committee’s decision will be communicated via email in the last week of May 2021 ONLY to the presenting (= first named) author’s contact e-mail entered in the online abstract submission tool.
Short Oral Discussions
Short oral discussions rank equally with oral presentations at the virtual EASD Meeting. A short pre-recorded PowerPoint presentation including audio must be uploaded to the EASD virtual meeting platform by the indicated deadline prior to the start of the virtual meeting; this will allow attendees to pre-view the short presentation and thus be able to follow the short summary by the presenter and engage in the discussion during the live/ interactive and moderated short oral discussion session. Detailed instructions will be sent to the presenting author on notification of acceptance (ONLY to the presenting (= first named) author’s contact e-mail entered in the online abstract submission tool) online abstract submission tool).
PowerPoint presentation will be available for Oral Presentations. Instructions on presentation will be sent to the presenting authors on notification of acceptance (ONLY to the presenting (= first named) author’s contact e-mail entered in the online abstract submission tool). Only single projection is provided.
Oral Presentations during the EASD Annual Meeting will be live and interactive; they will also be made available as webcasts via the EASD Virtual Meeting.
Access the Abstract Submission
If you are a member of EASD or you already have an account for the EASD Virtual Meeting or Annual Meeting registration, you can use the login details from your existing account (email address and password) to login to MyEASD and access the Abstract Submission System for the Virtual EASD Annual Meeting 2021. If you do not remember your MyEASD login and password, the site offers the option to reset your password or contact the helpdesk. As a new user, you will need to create your MyEASD account first.
Once logged in MyEASD, please proceed to Abstract Submission where you will be able to start your New Abstract Submission.
The registration system for the virtual EASD Annual Meeting 2021 will open in February 2021.
EASD does not accept "blank" registrations. EASD does not charge VAT.
All rates are indicated in Euro. The term ”Paid-up EASD Member” refers to a person who is recorded at the EASD Office as a paid-up member before starting the registration process and the membership has to be valid during the Annual Meeting.
The press registration system will open in July 2021.
Press Registration to the 57th virtual Annual Meeting of the European Association for the Study of Diabetes is free of charge for all approved press/media representatives.
Journalists/media representatives are required to upload either their press credentials (press ID card, no business card) or a letter of assignment from the editorial office of their news organisation during the online registration.
Please note: Public relations personnel and industry exhibitors cannot register as press.
EASD reserves the right to deny press registration to anybody it considers not to meet these criteria.
The entire scientific programme and all areas of the virtual EASD Annual Meeting platform are open to registered journalists.
All abstracts presented at the EASD Annual Meeting are embargoed until the date and time of their presentation in the scientific programme. For Oral Presentations, the embargo is lifted at the beginning of the presentation; for Short Oral Discussions, the embargo is lifted at 11:59 CEST on Tuesday, 28 September 2021. All press releases distributed by EASD will clearly state the respective embargo time and date that may differ from the above stated embargo policy for abstracts.
Reproduction of images, graphs and other visual representations
Data presented during the meeting is strictly copyrighted and use of imagery or visual representations of data, audio and video recording is strictly prohibited. You may only use images, graphs and other visual representations of data from the presentations with the explicit permission of the abstract author/presenter.
EASD does not obtain approval for those wishing to reproduce images of graphs/data in their reporting. Failure to get permission and provide evidence of this, and failure to provide accurate accreditation, will result in a breach of copyright.
Recording, filming and screenshots
Recording, filming and taking screenshots is only allowed during virtual press conferences. Recording, filming and taking screenshots of other areas of the virtual Annual Meeting is subject to prior written approval from the EASD Press Centre staff. To record, film or to take screenshots of a presenter during his/her presentation, prior written approval from the presenter is required for permission to be granted by EASD. EASD does not obtain approval for those wishing to film, record or taking screenshots of a presenter.
Recording, filming and taking screenshots of the virtual Industry Exhibition is strictly forbidden.
The official hashtag of the virtual EASD Annual Meeting 2021 is #EASD2021. Please use it in all tweets or posts related to the 57th virtual EASD Annual Meeting. Please refer to the Social Media section for more information.
Online Press Centre
Journalists registered to the EASD Annual Meeting can access the EASD 2021 online Press Centre with the login information from their press registration account. The online press Centre provides materials such as the press conference schedule, press statements from invited speakers, abstracts and speaker bios. Press releases will be distributed to registered press delegates throughout the meeting.
Third parties may distribute press releases or press kits in the online Press Centre, materials must be send to email@example.com. Third party press releases must clearly display the embargo date and time of the presentation at the EASD Annual Meeting, the company issuing the release assumes responsibility for ensuring embargoed releases are only distributed to reporters who will abide by the EASD’s embargo policies.
EASD will organize a series of press briefings throughout the Annual Meeting. A detailed schedule will be available for registered press delegates closer to the date.
Third party press conferences are permitted however, they cannot be held at the same time as an EASD press conference. Third parties wishing to conduct a press conference should first contact Mr. Oliver Heinke (firstname.lastname@example.org) at our PCO Interplan for technical options and requirements.
The EASD press office will distribute invitations for third party press conferences to press/media registered to the virtual EASD Annual Meeting 2021 and add them to the press conference schedule in the EASD online Press Centre.
The official hashtag of the virtual EASD Annual Meeting 2021 is #EASD2021. Please use it in all tweets or posts related to the 57th EASD Annual Meeting.
Social Media Rules
EASD encourages delegates and participants of the virtual EASD Annual Meeting 2021 to publish and share tweets and posts related to the Annual Meeting and the Scientific Programme within the following rules:
EASD reserves the right to remove comments, tweets or posts it deems, in its sole discretion, to be inappropriate and that do not follow the Social Media rules written above.
The views, information, or opinions expressed in tweets and posts under #EASD2021 are solely those of the individual user and do not necessarily represent those of EASD. EASD is not responsible and does not verify for accuracy any of the information published under #EASD2021. EASD cannot be held liable for any misuse of #EASD2021.
Monday, 27 September 2021 - Friday, 1 October 2021
All efforts will be made to adhere to the programme as printed. However, EASD and its agents reserve the right to alter or cancel, without prior notice, any of the arrangements, timetables, plans or other items relating directly or indirectly to the Meeting, for any case beyond their reasonable control.
EASD and its agents are not liable for any other loss or inconvenience caused as a result of such changes.
Modification of the Programme
The organiser will make all efforts to adhere to the programme advertised. However, the organiser and its agents reserve the right to alter, replace or cancel, without prior notice, any of the speakers or arrangements announced, provided that the overall character of the event remains unaffected. The organiser will inform the attendees to that effect immediately by publishing details of the modification on the website. If those modifications are caused by any factor outside of the reasonable control and the responsibility of the organiser (e.g. a speaker is suddenly prevented from attending, any unforeseeable disruption at the venue), the organiser will not be liable for any loss or inconvenience caused as a result of such modifications.
Cancellation of the Annual Meeting
The organiser reserves the right to withdraw from the contract in whole or in part and to cancel the Annual Meeting if the performance of the same is impossible due to force majeure or other unforeseen incidents outside its responsibility including, without limitation, strike, lock-out, natural disasters, terrorism, riots, war, disorder, and acts of public authorities. The organiser will inform the attendees to that effect immediately.
In this case, the organiser cannot be held liable by the attendee for any damages, costs, or losses incurred, such as transportation, accommodation, costs for additional orders, financial losses, etc. caused by the slight negligence of the organiser, its legal representatives or vicarious agents. Apart from that, the limitation of liability remains unaffected.
Under these circumstances, the organiser will refund the registration fee but reserves the right to deduct any costs from the registration fee which have already been incurred for the organisation of the Annual Meeting and which cannot be recovered from third parties.
Limitation of Liability
The organiser is liable without restriction for any damage arising from loss of life, personal injury or illness caused by the organiser, its legal representatives or vicarious agents.
In the event of any other damage caused by the organiser, its legal representatives or vicarious agents, liability is limited to intentionally or grossly negligent conduct.
The above does not apply to claims relating to breaches of fundamental contract obligations. Fundamental contract obligations are those the performance of which is essential to the contract and on which the attendee may rely. In the event of a breach of fundamental contract obligations caused by the slight negligence of the organiser, its legal representatives or vicarious agents, the organiser’s liability for all damage is limited to the foreseeable damages typical of the contract.
Data Protection and Sharing of Contact Details
Applicable Law and Jurisdiction
German law applies. The application of the United Nations Convention on Contracts for the International Sale of Goods (CISG) is excluded. The court is Düsseldorf, Germany. This does not affect (i) the right of consumers to assert claims in a court with jurisdiction in their state of habitual residence or (ii) mandatory rules applicable in such state.